The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
80870132 8087013 2 F 201010 20121019 20110811 20121029 EXP US-ABBOTT-11P-163-0844994-00 ABBOTT 74.45 M Y 84.44000 KG 20121029 CN COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
80870132 8087013 1 PS HUMIRA 40 MG/0.8 ML PEN 1 SUBCUTANEOUS D UNKNOWN 125057 40 MG QOW
80870132 8087013 2 SS HUMIRA 40 MG/0.8 ML PEN 1 D UNKNOWN 125057
80870132 8087013 3 SS BACTRIM DS 1 D UNKNOWN 0
80870132 8087013 4 C LISINOPRIL 1 D 0
80870132 8087013 5 C COREG 1 3.125MG TWICE DAILY D 0
80870132 8087013 6 C PENTASA 1 D 0 250 MG QD
80870132 8087013 7 C KEPPRA 1 D 0 250 MG QD
80870132 8087013 8 C PRILOSEC 1 D 0 20 MG QD
80870132 8087013 9 C PRILOSEC 1 D 0
80870132 8087013 10 C ALBUTEROL 1 INHALATION INHALER PUFF IN MORNING AND PUFF AT NIGHT AS NEEDED D 0 1 DF
80870132 8087013 11 C COPIUM BROMIDE 2 INHALATION WITH BREATHING MACHINE 2-3 TIMES A DAY D 0
80870132 8087013 12 C COPIUM BROMIDE 2 D 0
80870132 8087013 13 C OXYGEN 1 AT NIGHT DURING SLEEP D 0 2 L
80870132 8087013 14 C METOPROLOL 1 D 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
80870132 8087013 1 Psoriatic arthropathy
80870132 8087013 2 Psoriasis
80870132 8087013 3 Diarrhoea
80870132 8087013 4 Product used for unknown indication
80870132 8087013 5 Product used for unknown indication
80870132 8087013 6 Colitis ulcerative
80870132 8087013 7 Complex partial seizures
80870132 8087013 8 Dyspepsia
80870132 8087013 9 Gastrooesophageal reflux disease
80870132 8087013 10 Asthma
80870132 8087013 11 Chronic obstructive pulmonary disease
80870132 8087013 12 Respiratory tract congestion
80870132 8087013 13 Chronic obstructive pulmonary disease
80870132 8087013 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
80870132 8087013 OT
80870132 8087013 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
80870132 8087013 Abasia
80870132 8087013 Arthralgia
80870132 8087013 Asthenia
80870132 8087013 Cardiac disorder
80870132 8087013 Cardiac output decreased
80870132 8087013 Cardiac stress test abnormal
80870132 8087013 Chest pain
80870132 8087013 Coronary artery occlusion
80870132 8087013 Device malfunction
80870132 8087013 Diarrhoea
80870132 8087013 Dyspepsia
80870132 8087013 Dyspnoea
80870132 8087013 Ejection fraction abnormal
80870132 8087013 General physical health deterioration
80870132 8087013 Hiccups
80870132 8087013 Immune system disorder
80870132 8087013 Myocardial infarction
80870132 8087013 Psoriasis
80870132 8087013 Unevaluable event

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
80870132 8087013 1 201006 20110206 0
80870132 8087013 3 201108 201108 0
80870132 8087013 4 201102 0
80870132 8087013 5 201106 0
80870132 8087013 7 2007 0
80870132 8087013 10 1972 0